1 |
Endovascular MT, in addition to treatment with IV tPA in eligible patients, is recommended for anterior circulation large vessel occlusion ischemic strokes in patients presenting within 6 h of symptom onset (level 1A evidence) |
|
2 |
Public health campaigns regarding stroke symptoms, their emergency nature (necessitating use of the 9-1-1 EMS system), and the availability of time-sensitive treatments are needed |
|
3 |
Systems of care focused upon the out-of-hospital triage and transport of patients to specialized treatment centers are now required for ischemic stroke, analogous to systems that have evolved for STEMI and trauma patients; a multisociety collaborative approach akin to the American Heart Association's ‘STEMI Mission Lifeline’ project [17] could help drive development of such LVO AIS systems of care |
|
4 |
Endovascular MT-capable hospitals should meet specific requirements regarding AIS and endovascular case volume, infrastructure, 24/7 imaging and clinical expertise, efficient workflow and procedural and clinical outcomes, all followed with specific performance measures as outlined |
|
5 |
The CSC model must evolve given the marked differences in both the prevalence and treatment acuity of acute ischemic stroke compared to aSAH; the number of MT-capable hospitals necessary to treat LVO AIS patients will likely be far greater than the number of centers required to treat the relatively low volume of aSAH patients; two categories of CSCs are thus likely necessary: those centers that have high volumes of AIS patients alone and those centers that remain referral centers of hemorrhage stroke as well |